Home / Cancer and immune system / Imatinib
ATC L01EA01 · Antineoplastic Agents
Imatinib shortage
As of 31 Oct 2026, Imatinib has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 5 products.
Countries3/5
Products5packs or presentations
Short since10 Aug 20263 months ago
Earliest return10 Nov 2026company estimate
No return date2products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | IMATINIB ACCORD | ACCORD HEALTHCARE, S.L.U. | 31 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | IMATINIB DR. REDDY'S announced | DR. REDDY'S S.R.L. | 16 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | IMATINIB TEVA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | Teva B.V. | 10 Aug 2026 | 10 Nov 2026 | Not stated |
| ES | IMATINIB TEVA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | Teva B.V. | 27 Oct 2026 | 10 Dec 2026 | Not stated |
| BE | Imatinib Teva 100 mg film-coat. tabl. 120 (120 x 1) UD | Teva | 12 Oct 2026 | 21 Dec 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.